Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2026-01-16 @ 8:40 PM
Study NCT ID:
NCT04851535
Status:
COMPLETED
Last Update Posted:
2023-11-03
First Post:
2021-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.
Sponsor:
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Myelofibrosis | View |
Keywords: